![Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface* - Journal of Biological Chemistry Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface* - Journal of Biological Chemistry](https://www.jbc.org/cms/asset/aec2f7c3-f87a-430f-be88-c6f8f0a8b04c/gr1.jpg)
Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface* - Journal of Biological Chemistry
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica
![IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells](https://www.mdpi.com/ijms/ijms-18-00537/article_deploy/html/images/ijms-18-00537-g006.png)
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
![Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2017.36/MediaObjects/41375_2017_Article_BFleu201736_Fig1_HTML.jpg)
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
![STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology](https://www.thelancet.com/cms/attachment/31294ecf-078e-46ab-9d0f-734d104fe7a1/gr4_lrg.jpg)
STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology
![IJMS | Free Full-Text | The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors IJMS | Free Full-Text | The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors](https://www.mdpi.com/ijms/ijms-14-16348/article_deploy/html/images/ijms-14-16348f1.png)
IJMS | Free Full-Text | The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors
![Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12964-021-00739-6/MediaObjects/12964_2021_739_Fig1_HTML.png)
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
![Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. - Australian Medical Student Journal Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. - Australian Medical Student Journal](http://www.amsj.org/wp-content/uploads/2017/08/Picture1.png)
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. - Australian Medical Student Journal
![Frontiers | The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach Frontiers | The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach](https://www.frontiersin.org/files/Articles/649434/fcell-09-649434-HTML/image_m/fcell-09-649434-g001.jpg)
Frontiers | The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach
![A model for the regulation of BCR-ABL nuclear import through conformational interplay between the kinase domain, the FABD and the NLS region. A model for the regulation of BCR-ABL nuclear import through conformational interplay between the kinase domain, the FABD and the NLS region.](https://s3-eu-west-1.amazonaws.com/ppreviews-plos-725668748/799931/preview.jpg)
A model for the regulation of BCR-ABL nuclear import through conformational interplay between the kinase domain, the FABD and the NLS region.
![Schematic representation of the mechanism of action of the BCR-ABLTKIs.... | Download Scientific Diagram Schematic representation of the mechanism of action of the BCR-ABLTKIs.... | Download Scientific Diagram](https://www.researchgate.net/publication/44662876/figure/fig1/AS:337835585490944@1457557688178/Schematic-representation-of-the-mechanism-of-action-of-the-BCR-ABLTKIs-The-BCR-ABL.png)
Schematic representation of the mechanism of action of the BCR-ABLTKIs.... | Download Scientific Diagram
![Mechanism of Action of BCR-ABL and of Its Inhibition by Imatinib. Panel... | Download Scientific Diagram Mechanism of Action of BCR-ABL and of Its Inhibition by Imatinib. Panel... | Download Scientific Diagram](https://www.researchgate.net/publication/11492545/figure/fig1/AS:601578448879617@1520438887076/Mechanism-of-Action-of-BCR-ABL-and-of-Its-Inhibition-by-Imatinib-Panel-A-shows-the.png)
Mechanism of Action of BCR-ABL and of Its Inhibition by Imatinib. Panel... | Download Scientific Diagram
![The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004221000468-fx1.jpg)
The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect
![BCR-ABL signaling mimics growth factor activation. Growth factors are... | Download Scientific Diagram BCR-ABL signaling mimics growth factor activation. Growth factors are... | Download Scientific Diagram](https://www.researchgate.net/publication/51238937/figure/fig1/AS:305846417412097@1449930876720/BCR-ABL-signaling-mimics-growth-factor-activation-Growth-factors-are-known-to-activate.png)